Our results showed that the expression of YAP1 gene, as well as its target genes (AMOTL2, CYR61, CTGF, MYC, GLI2, and AXL) increased significantly in the poor prognostic group of IBC patients (Fig. S2E, p < 0.01). This evidence concerns the gene MYC and inflammatory breast carcinoma.